Calton & Associates’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,374
Closed -$50K 447
2017
Q4
$50K Buy
+1,374
New +$49.6K 0.01% 682

Other funds holding BME

Calton & Associates's BME Position: Q1 2018 in Review

Calton & Associates sold out of BlackRock Health Sciences Trust (BME) in Q1 2018, closing a stake of 1,374 shares — an estimated $50K sold.

Calton & Associates first reported a position in BME in Q4 2017 and held it in 1 quarter. The position peaked at $50K in Q4 2017. 39 funds tracked by Wall St. Rank hold BME as of Q1 2018.

  • Calton & Associates reported no remaining BlackRock Health Sciences Trust position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 1,374 BlackRock Health Sciences Trust shares in Q1 2018, an estimated $50K.
  • Calton & Associates first reported a position in BlackRock Health Sciences Trust in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's BlackRock Health Sciences Trust position peaked at $50K in Q4 2017.
  • 39 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.